Pain drug in pipeline as researchers unwind marine snail puzzle

Pain drug in pipeline as researchers unwind marine snail puzzle
Credit: David Wilson

A University of Queensland researcher has made a big step toward the holy grail of biomedical science—a new form of effective pain relief.

School of Biomedical Sciences researcher Dr Richard Clark said marine snail was a well-known and promising source of new pain drugs, but substantial hurdles had restrained progress.

"Translating the venom's toxins into a viable drug has proved difficult," Dr Clark said.

"But now we've been able to identify a core component of one of these conotoxins (toxins from cone snail venom) during laboratory tests.

"We think this will make it much easier to translate the active ingredient into a useful drug."

Dr Clark said a sea snail used its venom to immobilise prey and protect itself.

"The venom's analgesic have been well researched," he said.

"In this study, we've been able to shrink a particular conotoxin to its minimum necessary components for the pain relief properties to continue to work.

"Using a laboratory rat model, we used the modified conotoxin to successfully treat pain generated in the colon, similar to that experienced by humans with .

"Although the conotoxin has been modified, its properties remained as effective as the full-size model.

"Simplifying the conotoxin will make a drug much faster and cheaper to develop."

Dr Clark said further research was under way to improve the modified conotoxin's stability and to test its ability to treat other types of pain.

The research, published in Angewandte Chemie International Edition, was undertaken in collaboration with Professor David Craik at UQ's Institute for Molecular Bioscience, Professor David Adams at the Royal Melbourne Institute of Technology and Associate Professor Stuart Brierley at the University of Adelaide.

Explore further

Advance toward developing an oral pain reliever derived from debilitating snail venom

More information: Bodil B. Carstens et al. Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA Receptor Activation Reveal a Minimal Functional Motif , Angewandte Chemie International Edition (2016). DOI: 10.1002/anie.201600297
Citation: Pain drug in pipeline as researchers unwind marine snail puzzle (2016, April 13) retrieved 30 July 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments